Evidence map›Paper›PMID 39015121›Full record

ArticleCase reports in nephrology and dialysis

O80:H2-Associated Hemolytic Uremic Syndrome without Hemorrhagic Colitis: A Case Report.

Sawako Yoshida, Eriko Tanaka, Zentaro Kiuchi, Saaya Nunokawa, Ayumi Kawahara, Sunao Iyoda, Masami Narita

Abstract readCase Reports
In one paragraph

Article in Case reports in nephrology and dialysis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Emerging hybrid shigatoxigenic and enteropathogenicClinical microbiology reviews · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sawako YoshidaDepartment of Pediatrics, Kyorin University School of Medicine, Tokyo, Japan.
Eriko TanakaDepartment of Pediatrics, Kyorin University School of Medicine, Tokyo, Japan.
Zentaro KiuchiDepartment of Pediatrics, Kyorin University School of Medicine, Tokyo, Japan.
Saaya NunokawaDepartment of Pediatrics, Kyorin University School of Medicine, Tokyo, Japan.
Ayumi KawaharaDepartment of Pediatrics, Kyorin University School of Medicine, Tokyo, Japan.
Sunao IyodaDepartment of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan.
Masami NaritaDepartment of Pediatrics, Kyorin University School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Hemolytic uremic syndrome (HUS) is characterized by progressive kidney injury accompanied by thrombotic microangiopathy, which is clinically defined as microangiopathic hemolytic anemia with thrombocytopenia and organ injury. Shiga toxin-producing Case Presentation: We report the case of a 3-year-old girl diagnosed with STEC-HUS associated with a rare O80:H2 stx2 serotype, characterized by an atypical clinical course. She presented with severe hemolytic anemia and mild renal dysfunction but did not have enterohemorrhagic diarrhea. The first culture test of her stool sample collected using a swab upon admission yielded no signs of STEC, leading to an initial diagnosis of atypical HUS; thus, eculizumab was administered adding to red blood cell transfusion and recombinant thrombomodulin alfa and haptoglobin. However, a subsequent culture test of her second stool sample revealed the presence of O80:H2 stx2, confirming the diagnosis of STEC-HUS. Subsequently, the patient's condition improved, and her serum creatinine level gradually normalized over the course of 3 months. Conclusion: Diligently diagnosis is crucial in cases lacking typical STEC-HUS symptoms. We advocate for repeated stool culture testing to ensure accurate identification and timely management of such cases.

Indexed as

Case reportHemolytic uremic syndromeHemorrhagic colitisO80:H2Shiga toxin-producing Escherichia coli

Identifiers

PMID39015121
PMCPMC11249758

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.